NextPlat (NXPL) Non-Current Assets (2010 - 2026)
NextPlat's (NXPL) quarterly Non-Current Assets came in at $3.5 million in Q2 2026, down 15.61% year-over-year from $4.2 million in Q2 2025, and down 3.71% quarter-over-quarter from $3.7 million in Q1 2026.
Analysis
NextPlat (NXPL) Non-Current Assets (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Non-Current Assets for 13 consecutive years, with $3.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 15.61% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $14.3 million, a 25.57% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 33.79% from the prior year.
- Non-Current Assets was $3.5 million for Q2 2026 at NextPlat, down from $3.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $22.5 million in Q3 2023 and troughed at $1.2 million in Q1 2022.
- A 5-year average of $7.6 million and a median of $5.2 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 529.55% in 2023 and sank 76.37% in 2024, its largest moves.
- Over 5 years, Non-Current Assets stood at $7.5 million in 2022, then jumped by 179.2% to $20.8 million in 2023, then sank by 76.01% to $5.0 million in 2024, then sank by 33.79% to $3.3 million in 2025, then gained by 6.56% to $3.5 million in 2026.
- The last three Non-Current Assets figures came in at $3.5 million (Q2 2026), $3.7 million (Q1 2026), and $3.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 26.10 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 24.99 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 2.92 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.83 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 18.27 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 668.68 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.04 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 1.11 Bn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 3.25 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 3.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.53 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 3.31 Mn |
| Sep 30, 2025 | 3.80 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 4.73 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 9.42 Mn |
| Mar 31, 2024 | 19.72 Mn |
| Dec 31, 2023 | 20.83 Mn |
| Sep 30, 2023 | 22.46 Mn |
| Jun 30, 2023 | 6.70 Mn |
| Mar 31, 2023 | 7.29 Mn |
| Dec 31, 2022 | 7.46 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 2.26 Mn |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 1.15 Mn |